Fortune feature on RSV’s Philanthropy Model, “Corporate America’s philanthropy model doesn’t work. It’s time for a better one.” by Lindsay Androski, RSV CEO
Corporate America is exceedingly generous. With nearly $17 billion in donations in 2020 alone, businesses are working hard to address everything from equity to education to addiction.
Towards access for all: 1st Working Group Report for the Global Gene Therapy Initiative (GGTI)” published in Nature
The gene and cell therapy field saw its first approved treatments in Europe in 2012 and the United States in 2017 and is projected to be at least a $10B USD industry by 2025.